Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2019
ISBN 10: 3659909491 ISBN 13: 9783659909498
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2019
ISBN 10: 3659909491 ISBN 13: 9783659909498
Da: moluna, Greven, Germania
EUR 50,66
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: LAP Lambert Academic Publishing, 2019
ISBN 10: 3659909491 ISBN 13: 9783659909498
Da: Revaluation Books, Exeter, Regno Unito
EUR 105,80
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 144 pages. 8.66x5.91x0.47 inches. In Stock.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2019
ISBN 10: 3659909491 ISBN 13: 9783659909498
Da: preigu, Osnabrück, Germania
EUR 53,25
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. In Silico Design of Hemolysin Inhibitors | of Staphylococcus haemolyticus and Wet Laboratory Applications | Bakr Mohammed Ali Abdulmohsin | Taschenbuch | 144 S. | Englisch | 2019 | LAP LAMBERT Academic Publishing | EAN 9783659909498 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2019
ISBN 10: 3659909491 ISBN 13: 9783659909498
Da: Buchpark, Trebbin, Germania
EUR 54,02
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: Hervorragend. Zustand: Hervorragend | Sprache: Englisch | Produktart: Bücher | Staphylococcus haemolyticus strains are the second of the most frequently encountered Coagulase Negative Staphylococci that have been recognized as an emerging and important human pathogen causing serious infections such as endocarditis, urinary tract infections, septicemia, peritonitis, wound, bone and joint infections. Patients with the illnesses are usually immunocompromised, with indwelling or implanted foreign bodies . In Silico drug design represents a new approach for drug discovery and industry. This approach was used in this study to find multi-target inhibitors against the hemolysin proteins of the Staphylococcus haemolyticus which is considered the main virulence factor of this bacterium. One hundred thirty two samples were collected from wounds, ear swaps, blood cultures and from urine samples of Iraqi patients for bacterial identification from 1/12/2013 to 28/4/2014 period. Forty six of samples were diagnosed as Staphylococcus haemolyticus by biochemical tests. Almost all isolates had the ability to produce hemolysin at different degrees.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing Feb 2019, 2019
ISBN 10: 3659909491 ISBN 13: 9783659909498
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 61,90
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Staphylococcus haemolyticus strains are the second of the most frequently encountered Coagulase Negative Staphylococci that have been recognized as an emerging and important human pathogen causing serious infections such as endocarditis, urinary tract infections, septicemia, peritonitis, wound, bone and joint infections. Patients with the illnesses are usually immunocompromised, with indwelling or implanted foreign bodies . In Silico drug design represents a new approach for drug discovery and industry. This approach was used in this study to find multi-target inhibitors against the hemolysin proteins of the Staphylococcus haemolyticus which is considered the main virulence factor of this bacterium. One hundred thirty two samples were collected from wounds, ear swaps, blood cultures and from urine samples of Iraqi patients for bacterial identification from 1/12/2013 to 28/4/2014 period. Forty six of samples were diagnosed as Staphylococcus haemolyticus by biochemical tests. Almost all isolates had the ability to produce hemolysin at different degrees. 144 pp. Englisch.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2019
ISBN 10: 3659909491 ISBN 13: 9783659909498
Da: Majestic Books, Hounslow, Regno Unito
EUR 100,77
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2019
ISBN 10: 3659909491 ISBN 13: 9783659909498
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 101,11
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing Feb 2019, 2019
ISBN 10: 3659909491 ISBN 13: 9783659909498
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 61,90
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Staphylococcus haemolyticus strains are the second of the most frequently encountered Coagulase Negative Staphylococci that have been recognized as an emerging and important human pathogen causing serious infections such as endocarditis, urinary tract infections, septicemia, peritonitis, wound, bone and joint infections. Patients with the illnesses are usually immunocompromised, with indwelling or implanted foreign bodies . In Silico drug design represents a new approach for drug discovery and industry. This approach was used in this study to find multi-target inhibitors against the hemolysin proteins of the Staphylococcus haemolyticus which is considered the main virulence factor of this bacterium. One hundred thirty two samples were collected from wounds, ear swaps, blood cultures and from urine samples of Iraqi patients for bacterial identification from 1/12/2013 to 28/4/2014 period. Forty six of samples were diagnosed as Staphylococcus haemolyticus by biochemical tests. Almost all isolates had the ability to produce hemolysin at different degrees.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 144 pp. Englisch.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2019
ISBN 10: 3659909491 ISBN 13: 9783659909498
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 62,64
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Staphylococcus haemolyticus strains are the second of the most frequently encountered Coagulase Negative Staphylococci that have been recognized as an emerging and important human pathogen causing serious infections such as endocarditis, urinary tract infections, septicemia, peritonitis, wound, bone and joint infections. Patients with the illnesses are usually immunocompromised, with indwelling or implanted foreign bodies . In Silico drug design represents a new approach for drug discovery and industry. This approach was used in this study to find multi-target inhibitors against the hemolysin proteins of the Staphylococcus haemolyticus which is considered the main virulence factor of this bacterium. One hundred thirty two samples were collected from wounds, ear swaps, blood cultures and from urine samples of Iraqi patients for bacterial identification from 1/12/2013 to 28/4/2014 period. Forty six of samples were diagnosed as Staphylococcus haemolyticus by biochemical tests. Almost all isolates had the ability to produce hemolysin at different degrees.